相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single-Dose and Multiple-Ascending-Dose Phase 1 Studies in Healthy Adults
Ishani Landry et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea
Marie-Laure Boof et al.
SLEEP (2021)
Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Jack D. Edinger et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2021)
Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder
Margaret Moline et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2021)
Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline
Jack D. Edinger et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2021)
Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice
Mahesh K. Kaushik et al.
SLEEP (2021)
Lemborexant for the Treatment of Insomnia: Direct and Indirect Comparisons With Other Hypnotics Using Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Leslie Citrome et al.
JOURNAL OF CLINICAL PSYCHIATRY (2021)
Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials
Margaret Moline et al.
POSTGRADUATE MEDICINE (2021)
Nocturnal cognitive arousal is associated with objective sleep disturbance and indicators of physiologic hyperarousal in good sleepers and individuals with insomnia disorder *
David A. Kalmbach et al.
SLEEP MEDICINE (2020)
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
W. Joseph Herring et al.
ALZHEIMERS & DEMENTIA (2020)
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
Yves Dauvilliers et al.
ANNALS OF NEUROLOGY (2020)
Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening
Patricia Murphy et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2020)
Changes in dysfunctional beliefs about sleep after cognitive behavioral therapy for insomnia: A systematic literature review and meta-analysis
Manu Thakral et al.
SLEEP MEDICINE REVIEWS (2020)
Selecting a pharmacotherapy regimen for patients with chronic insomnia
Amanda B. Hassinger et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
0477 Characteristics of Insomnia Subjects Screened for Transitioning from Zolpidem Tartrate to Lemborexant in a Multicenter Pilot Study
M Ahmad et al.
SLEEP (2020)
0504 Efficacy and Safety of Seltorexant in Insomnia Disorder
A Savitz et al.
SLEEP (2020)
0478 A Multicenter Pilot Study to Evaluate Next-Dose Transition from Zolpidem to Lemborexant for the Treatment of Insomnia
R Rosenberg et al.
SLEEP (2020)
A randomized controlled trial of digital cognitive behavioral therapy for insomnia in pregnant women
David A. Kalmbach et al.
SLEEP MEDICINE (2020)
Effects of orexin receptor antagonism on human sleep architecture: A systematic review
Jacob W. Clark et al.
SLEEP MEDICINE REVIEWS (2020)
Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study
Jocelyn Y. Cheng et al.
JOURNAL OF SLEEP RESEARCH (2020)
Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder
Gary Zammit et al.
NEUROLOGY (2020)
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Mikko Karppa et al.
SLEEP (2020)
Clarifying the role of sleep in depression: A narrative review
Seithikurippu R. Pandi-Perumal et al.
PSYCHIATRY RESEARCH (2020)
The Prevalence of Insomnia Subtypes in Relation to Demographic Characteristics, Anxiety, Depression, Alcohol Consumption and Use of Hypnotics
Ingrid Bjoroy et al.
FRONTIERS IN PSYCHOLOGY (2020)
Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years
Charles M. Morin et al.
JAMA NETWORK OPEN (2020)
Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials
Hui Ling Soh et al.
SLEEP MEDICINE (2020)
Hypnotic Discontinuation in Chronic Insomnia
Jonathan P. Hintze et al.
SLEEP MEDICINE CLINICS (2020)
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults
Donna M. Fick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Cognitive Behavioral Therapy for Prenatal Insomnia A Randomized Controlled Trial
Rachel Manber et al.
OBSTETRICS AND GYNECOLOGY (2019)
Cognitive behavioural treatment for insomnia in primary care: a systematic review of sleep outcomes
Judith R. Davidson et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2019)
Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration
Clemens Muehlan et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Improving Daytime Functioning, Work Performance, and Quality of Life in Postmenopausal Women With Insomnia: Comparing Cognitive Behavioral Therapy for Insomnia, Sleep Restriction Therapy, and Sleep Hygiene Education
David A. Kalmbach et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2019)
Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trial
Philip Cheng et al.
SLEEP (2019)
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
Kasper Recourt et al.
TRANSLATIONAL PSYCHIATRY (2019)
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia
Sander Brooks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Treating chronic insomnia in postmenopausal women: a randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education
Christopher L. Drake et al.
SLEEP (2019)
On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
Annemiek Vermeeren et al.
SLEEP (2019)
Treating insomnia improves depression, maladaptive thinking, and hyperarousal in postmenopausal women: comparing cognitive-behavioral therapy for insomnia (CBTI), sleep restriction therapy, and sleep hygiene education
David A. Kalmbach et al.
SLEEP MEDICINE (2019)
Orexin Receptor Blockade-Induced Sleep Preserves the Ability to Wake in the Presence of Threat in Mice
Shouhei Iwakawa et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder A Phase 3 Randomized Clinical Trial
Russell Rosenberg et al.
JAMA NETWORK OPEN (2019)
Cognitive Behavioral Therapy for Insomnia and Women's Health Sex as a Biological Variable
Sara Nowakowski et al.
SLEEP MEDICINE CLINICS (2019)
Automatic affective responses towards the bed in patients with primary insomnia: evidence for a negativity bias
Nicolas Koranyi et al.
JOURNAL OF SLEEP RESEARCH (2018)
Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review
Erin Koffel et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2018)
Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study
Suzanne M. Bertisch et al.
SLEEP (2018)
A novel forehead temperature-regulating device for insomnia: a randomized clinical trial
Thomas Roth et al.
SLEEP (2018)
Recent Advancements in Treating Sleep Disorders in Co-Occurring PTSD
Peter J. Colvonen et al.
CURRENT PSYCHIATRY REPORTS (2018)
Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study
Suzanne M. Bertisch et al.
SLEEP (2018)
A novel forehead temperature-regulating device for insomnia: a randomized clinical trial
Thomas Roth et al.
SLEEP (2018)
An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
Kayla Janto et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2018)
9 The Global Problem of Insufficient Sleep and Its Serious Public Health Implications
Vijay Kumar Chattu et al.
HEALTHCARE (2018)
Insomnia and Impaired Quality of Life in the United States
Mark Olfson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Insomnia Treatment Preferences During Pregnancy
Ivan D. Sedov et al.
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING (2017)
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
Michael J. Sateia et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Murphy et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
Carsten Theodor Beuckmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Neural Circuitry of Wakefulness and Sleep
Thomas E. Scammell et al.
NEURON (2017)
Orexin System: The Key for a Healthy Life
Sergio Chieffi et al.
FRONTIERS IN PHYSIOLOGY (2017)
Essentials of Polysomnography: A Training Guide and Reference for Sleep Technicians
Joseph T. Daley et al.
SLEEP (2017)
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2016)
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
W. Joseph Herring et al.
BIOLOGICAL PSYCHIATRY (2016)
A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia
Kathryn M. Connor et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials
W. Joseph Herring et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2016)
Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea
Hong Sun et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2016)
CBT-I Coach: A Description and Clinician Perceptions of a Mobile App for Cognitive Behavioral Therapy for Insomnia
Eric Kuhn et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2016)
On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly
Annemiek Vermeeren et al.
PSYCHOPHARMACOLOGY (2016)
Guided Online or Face-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled Trial
Jaap Lancee et al.
SLEEP (2016)
Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data
Ellen Snyder et al.
SLEEP MEDICINE (2016)
Guided Online or Face-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled Trial
Jaap Lancee et al.
SLEEP (2016)
Suvorexant: a promising, novel treatment for insomnia
Joyce K. Lee-Iannotti et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Referral Practices for Cognitive Behavioral Therapy for Insomnia: A Survey Study
Deirdre A. Conroy et al.
BEHAVIOURAL NEUROLOGY (2015)
The Pathophysiology of Insomnia
Jessica C. Levenson et al.
CHEST (2015)
The Nature of Stable Insomnia Phenotypes
Vivek Pillai et al.
SLEEP (2015)
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers
Annemiek Vermeeren et al.
SLEEP (2015)
A cross-sectional study on the relationships among the polymorphism of period2 gene, work stress, and insomnia
Ju Li et al.
SLEEP AND BREATHING (2015)
The role of sleep hygiene in promoting public health: A review of empirical evidence
Leah A. Irish et al.
SLEEP MEDICINE REVIEWS (2015)
Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions A Meta-analysis
Jade Q. Wu et al.
JAMA INTERNAL MEDICINE (2015)
The Nature of Stable Insomnia Phenotypes
Vivek Pillai et al.
SLEEP (2015)
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers
Annemiek Vermeeren et al.
SLEEP (2015)
Suvorexant in insomnia: efficacy, safety and place in therapy
Danielle N. Rhyne et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2015)
Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson et al.
LANCET NEUROLOGY (2014)
Reducing Dysfunctional Beliefs about Sleep Does Not Significantly Improve Insomnia in Cognitive Behavioral Therapy
Isa Okajima et al.
PLOS ONE (2014)
Stress and Sleep Reactivity: A Prospective Investigation of the Stress-Diathesis Model of Insomnia
Christopher L. Drake et al.
SLEEP (2014)
Sleep duration and obesity among adults: a meta-analysis of prospective studies
Yili Wu et al.
SLEEP MEDICINE (2014)
Who is predisposed to insomnia: A review of familial aggregation, stress-reactivity, personality and coping style
Christopher-James Harvey et al.
SLEEP MEDICINE REVIEWS (2014)
Comparative Efficacy of Behavior Therapy, Cognitive Therapy, and Cognitive Behavior Therapy for Chronic Insomnia: A Randomized Controlled Trial
Allison G. Harvey et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2014)
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
Anthony L. Gotter et al.
BMC NEUROSCIENCE (2013)
The Relation between Insomnia Symptoms, Mood, and Rumination about Insomnia Symptoms
Colleen E. Carney et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2013)
Insomnia with objective short sleep duration: The most biologically severe phenotype of the disorder
Alexandros N. Vgontzas et al.
SLEEP MEDICINE REVIEWS (2013)
Insomnia With Short Sleep Duration Nosologic, Diagnostic, and Treatment Implications
Alexandros N. Vgontzas et al.
SLEEP MEDICINE CLINICS (2013)
Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia
Paolo Bettica et al.
NEUROPSYCHOPHARMACOLOGY (2012)
PER3 Polymorphism and Insomnia Severity in Alcohol Dependence
Kirk J. Brower et al.
SLEEP (2012)
Dismantling Multicomponent Behavioral Treatment for Insomnia in Older Adults: A Randomized Controlled Trial
Dana R. Epstein et al.
SLEEP (2012)
Chronic insomnia, quality-of-life, and utility scores: Comparison with good sleepers in a cross-sectional international survey
Damien Leger et al.
SLEEP MEDICINE (2012)
Efficacy of Brief Behavioral Treatment for Chronic Insomnia in Older Adults
Daniel J. Buysse et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Perceived Effectiveness of Diverse Sleep Treatments in Older Adults
Nalaka S. Gooneratne et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Sleep Reactivity and Insomnia: Genetic and Environmental Influences
Christopher L. Drake et al.
SLEEP (2011)
The societal costs of insomnia
Alan G. Wade
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2011)
Good night and good luck: Norepinephrine in sleep pharmacology
Heather A. Mitchell et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Systematic Analysis of Circadian Genes in a Population-Based Sample Reveals Association of TIMELESS with Depression and Sleep Disturbance
Siddheshwar J. Utge et al.
PLOS ONE (2010)
Insomnia severity is an indicator of suicidal ideation during a depression clinical trial
W. Vaughn McCall et al.
SLEEP MEDICINE (2010)
Drug-Related Sleep Stage Changes: Functional Significance and Clinical Relevance
Timothy Roehrs et al.
SLEEP MEDICINE CLINICS (2010)
A Mindfulness-Based Approach to the Treatment of Insomnia
Jason Ong et al.
JOURNAL OF CLINICAL PSYCHOLOGY (2010)
Distinguishing rumination from worry in clinical insomnia
Colleen E. Carney et al.
BEHAVIOUR RESEARCH AND THERAPY (2010)
MINDFULNESS MEDITATION AND COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA: A NATURALISTIC 12-MONTH FOLLOW-UP
Jason C. Ong et al.
EXPLORE-THE JOURNAL OF SCIENCE AND HEALING (2009)
Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent Insomnia A Randomized Controlled Trial
Charles M. Morin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Insomnia with Objective Short Sleep Duration is Associated with a High Risk for Hypertension
Alexandros N. Vgontzas et al.
SLEEP (2009)
Stepped Care: A Health Technology Solution for Delivering Cognitive Behavioral Therapy as a First Line Inysomnia Treatment
Colin A. Espie
SLEEP (2009)
Management of Hypnotic Discontinuation in Chronic Insomnia
Lynda Belanger et al.
SLEEP MEDICINE CLINICS (2009)
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: A 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study
Andrew D. Krystal et al.
SLEEP (2008)
Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia
Rachel Manber et al.
SLEEP (2008)
Predictors of primary medical care consultation for sleep disorders
Delwyn J. Bartlett et al.
SLEEP MEDICINE (2008)
Combining mindfulness meditation with cognitive-behavior therapy for insomnia: A treatment-development study
Jason C. Ong et al.
BEHAVIOR THERAPY (2008)
Comorbidity of chronic insomnia with medical problems
Daniel J. Taylor et al.
SLEEP (2007)
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder
M Fava et al.
BIOLOGICAL PSYCHIATRY (2006)
Epidemiology of insomnia:: Prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors
CM Morin et al.
SLEEP MEDICINE (2006)
Epidemiology of insomnia, depression, and anxiety
DJ Taylor et al.
SLEEP (2005)
An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic condition
D Leger et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Hypothalamic regulation of sleep and circadian rhythms
CB Saper et al.
NATURE (2005)
Inadequate sleep as a risk factor for obesity: Analyses of the NHANES I
JE Gangwisch et al.
SLEEP (2005)
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index
S Taheri et al.
PLOS MEDICINE (2004)
Functional neuroimaging evidence for hyperarousal in insomnia
EA Nofzinger et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Insomnia, metabolic rate and sleep restoration
MH Bonnet et al.
JOURNAL OF INTERNAL MEDICINE (2003)
分享论文
